| Metric | Value (₹ Cr) | Q4 FY25 |
|---|---|---|
| Revenue | 1.1K | 13.7% |
| Total Income | 1.1K | 13.7% |
| Expenditure | 1.0K | 10.2% |
| PBT | 52.48 | 213.0% |
| Net Profit | 37.05 | 201.6% |
| OPM | 5.81% | 2.32pp |
| NPM | 3.38% | 2.11pp |
| EPS | 4.16 | 249.6% |
Gandhar Oil FY26 PAT Up 64% to ₹137.2 Cr
26 May 2026 · 26 May, 10:12 pm
Summary
Gandhar Oil Refinery (India) Ltd concluded FY26 with a strong performance, reporting Q4FY26 consolidated revenues of ₹1,093.4 Cr, a 14% year-on-year increase, and full-year revenues of ₹4,241.2 Cr. Operational profitability saw significant gains, with Q4FY26 EBITDA soaring by 88% to ₹63.6 Cr, while consolidated Profit After Tax (PAT) for the quarter more than tripled, rising by 201% to ₹37.0 Cr. For the full year, PAT grew to ₹137.2 Cr. Joint Managing Director Aslesh Parekh highlighted a strong close to FY26, driven by sustained domestic demand and a focus on higher-margin PHPO products. Despite macroeconomic pressures and geopolitical volatility, the company delivered robust results across all parameters and expressed confidence in its near- to medium-term growth outlook.
Key Highlights
- 1
Consolidated manufacturing sales volumes for FY26 increased by 9% to 5,45,755 KL from 5,00,231 KL in FY25.
- 2
Q4FY26 consolidated revenues stood at ₹1,093.4 Cr, representing a 14% year-on-year increase from ₹961.7 Cr in Q4FY25.
- 3
Full-year FY26 consolidated revenues reached ₹4,241.2 Cr, growing by 8.8% from ₹3,896.9 Cr in FY25.
- 4
Consolidated EBITDA for Q4FY26 surged by 88% to ₹63.6 Cr, compared to ₹33.6 Cr in Q4FY25.
- 5
Consolidated Profit After Tax (PAT) for Q4FY26 significantly grew by 201% to ₹37.0 Cr, up from ₹12.3 Cr in Q4FY25.
- 6
For the full year FY26, consolidated PAT stood at ₹137.2 Cr, marking a substantial 64.3% increase from ₹83.5 Cr in FY25.
- 7
The Pharmaceutical, Health Care, and Performance Oil (PHPO) segment remained the primary revenue driver for FY26, contributing 48% of the total consolidated revenue.
Management Comments
Aslesh Parekh
We delivered a strong close to FY26, supported by sustained momentum in domestic demand and a continued strategic focus on higher-margin PHPO products. This performance was achieved despite a challenging global environment characterized by macroeconomic pressures, ongoing logistical constraints, and volatility arising from the Middle East geopolitical situation, including the temporary closure of the Strait of Hormuz, which led to a sharp increase in oil prices. Notwithstanding these headwinds, we recorded robust performance across all parameters. In the fourth quarter of FY26, revenue stood at ₹1,093 crore, reflecting a year-on-year increase of 14%. Operational profitability remained robust, with EBITDA rising by 88% to ₹64 crore, while profit after tax (PAT) grew by 201% to ₹37 crore, supported by a favorable product mix and improved operating efficiencies. For the full year, revenue reached ₹4,241 crore, with EBITDA of ₹234 crore. This growth was underpinned by manufacturing sales volumes of 5,45,755 KL, representing a 9% increase over the previous year. The PHPO segment continued to be the primary growth driver, contributing 48% of total revenue, driven by strong demand from the personal care and healthcare sectors. Looking ahead, the domestic demand environment remains encouraging. Additionally, the anticipated easing of international logistical constraints, along with stabilizing input costs, is expected to further support business momentum. This provides us with confidence in our near- to medium-term growth outlook but we continue to remain cautious and watchful.”
Informational and educational content only. Not investment advice.